Atossa Therapeutics, Inc.

8-K Entered a material agreement Jun 11, 2026 8-K May 8, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Shareholder vote results May 8, 2026 8-K Other events Apr 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Mar 25, 2026 8-K Entered a material agreement; Terminated a material agreement Feb 20, 2026 8-K Delisting notice or listing-rule failure Feb 17, 2026 8-K Regulation FD disclosure Feb 11, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jan 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 9, 2026 8-K Other events Jan 6, 2026 8-K Other events Dec 4, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Director or officer change; Regulation FD disclosure Oct 14, 2025 8-K Regulation FD disclosure Sep 26, 2025 8-K Other events Sep 8, 2025 8-K Delisting notice or listing-rule failure Aug 21, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Shareholder vote results May 12, 2025 8-K Other events Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Results of operations (earnings release) Mar 25, 2025 8-K Other events Mar 12, 2025 8-K Delisting notice or listing-rule failure Feb 24, 2025 8-K Other events Feb 4, 2025 8-K Other events Dec 10, 2024 8-K Entered a material agreement Nov 19, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Other events Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jul 2, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024